ZEB1 inhibits LHβ subunit transcription when over-expressed, but is dispensable for LH synthesis in mice.
Hailey SchultzXiang ZhouCarlos Agustín Isidro AlonsoLuisina OngaroYeu-Farn LinMary LokaThomas BrabletzSimone BrabletzMarc P StemmlerUlrich BoehmDaniel J BernardPublished in: Endocrinology (2024)
Luteinizing hormone (LH), a heterodimeric glycoprotein produced by pituitary gonadotrope cells, regulates gonadal function. Hypothalamic gonadotropin-releasing hormone (GnRH) stimulates LH synthesis and secretion. GnRH induces LHβ subunit (Lhb) expression via the transcription factor, early growth response 1 (EGR1), acting on the Lhb promoter. In contrast, over-expression of zinc finger E-box binding homeobox 1 (ZEB1) represses LH production in mice, but the underlying mechanism was not previously elucidated. Here, we observed that ZEB1 inhibited GnRH-stimulated, but not basal Lhb mRNA expression in homologous murine LβT2 cells. Moreover, ZEB1 blocked GnRH and/or EGR1 induction of murine Lhb, but not human LHB promoter-reporter activity in these cells. Using chimeric reporters, we mapped the species-specific ZEB1 sensitivity to sequence differences, including in Z- and E-boxes, in the proximal Lhb/LHB promoters, immediately upstream of the transcription start sites. ZEB1 bound to the murine Lhb promoter with higher affinity than to the human LHB promoter in this region. To examine ZEB1's physiological role in LH synthesis, we characterized gonadotrope-specific Zeb1 knockout mice. Loss of ZEB1 in gonadotropes did not affect LH production or secretion. Collectively, the data suggest that ZEB1, when over-expressed, can inhibit GnRH/EGR1 induction of murine Lhb transcription but does not play a necessary role in LH synthesis in mice.
Keyphrases
- epithelial mesenchymal transition
- transcription factor
- long non coding rna
- poor prognosis
- dna methylation
- endothelial cells
- gene expression
- signaling pathway
- magnetic resonance
- high fat diet induced
- binding protein
- stem cells
- skeletal muscle
- dna binding
- metabolic syndrome
- dna damage
- computed tomography
- crispr cas
- cell therapy
- cell cycle arrest
- cell death
- electronic health record
- induced pluripotent stem cells
- machine learning
- insulin resistance
- amino acid